Tag: Screening

Absolute deficit in screening estimated at 3.9, 3.8, and 1.6 million for breast, colorectal, and prostate cancers, respectively

Multitarget stool DNA test, fecal immunochemical test, or guaiac-based fecal occult blood test preferred over colonoscopy

Asymptomatic brain metastases incidentally diagnosed in about 4 percent of patients with mRCC during clinical trial screening

New atrial fibrillation was detected in 1.5 percent of patients screened versus 0.3 percent of controls, who did not undergo screening

Those who have clinically recovered but continue to test positive on RT-PCR after the requisite isolation seem not to be infectious to others

Current evidence is lacking and balance of benefits and harms of screening cannot be determined

Online information needed to warn those with history of sinus, pituitary surgery to avoid nasopharyngeal swab testing, use alternative testing

Physicians should screen overweight, obese adults aged 35 to 70 years and refer those with prediabetes to preventive interventions

No significant difference in perinatal or maternal outcomes found with one-step versus two-step screening approach

Adults aged 50 to 80 years with 20 pack-year smoking history who currently smoke or quit within last 15 years should be screened with low-dose CT